- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Allergan Inc/United States
+ Add to WatchlistAGN:US
101.4100 USD 0.9900 0.99%
Share
As of 20:04:04 ET on 05/17/2013.
More on AGN
News for Allergan Inc/United States (AGN)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Obesity Surgery in India Spurs J&J Stomach-Staple Sales
- Governor Christie Had Weight Loss Surgery in February
- U.S. Stock Options With Biggest Changes in Implied Volatility
- S&P 500 Stocks Biggest Weekly Changes in Target Price
- Maker of Botox Plunges the Most in 13 Years
- Allergan Shares Fall After CEO Says Two Studies Delayed
- Allergan Shares Fall After CEO Says Drug Trial Will Be Delayed
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Solvency II Rules Seen as Costing U.K. Insurers $310 Million
- Cosmetic Procedures Need Tighter Restrictions: U.K. Panel
- Dutch Mortgage-Bond Market Threatened by Capital Rules, DSA Says
- Chili Peppers Seen Helping 36 Million Migraine Sufferers
- Allergan’s Migraine Drug Inhaler Levadex Rejected
- Allergan Investor Claims Over Botox Penalty Thrown Out
- EIOPA Begins Discussions on Insurers’ Interim Solvency Rules
- ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index Published 10 minutes ago
- ACADIA Pharmaceuticals Prices Public Offering of Common Stock Published May 15, 2013
- ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Published May 14, 2013
- KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results Published May 13, 2013
- True Results Reports That Only 1 in 21 Medically-Eligible People Are Likely to Consider Weight-Loss Surgery, Such as LAP-BAND, Published May 10, 2013
- ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results Published May 07, 2013
- FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Published May 02, 2013
- Allergan Reports First Quarter 2013 Operating Results Published May 01, 2013
- Tau Founder Dr. Timothy L. Macdonald Honored for Contributions to Virginia Bioscience Published May 01, 2013
- ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013 Published Apr 30, 2013
- Allergan Announces Death of Stephen J. Ryan, M.D. Published Apr 30, 2013
- FDA STAFF REVIEW OF ALLERGAN'S JUVEDERM VOLUMA XC Published Apr 30, 2013
- ACADIA Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference on April 30, 2013 Published Apr 25, 2013
- Allergan Welcomes 'Keogh Review' Recommendations to Classify All Cosmetic Implants as Medical Devices Published Apr 23, 2013
- Merck Insomnia Drug Safer at Lower Dose, FDA Staff Says Updated 26 minutes ago
- Actavis to Buy Warner Chilcott for $5 Billion Updated 47 minutes ago
- ‘Love Hormone’ Promises Safer Births After Pfizer Flop Updated 4 hours ago
- Elan Makes Two Acquisitions for $380 Million Updated 4 hours ago
- China’s Stocks Rise to Seven-Week High as Trading Volumes Surge
- Japan Biotech Firms Jump as Abenomics Cash Spurs Speculation
- Lundbeck-Takeda Drug Fights Depression Better at Higher Dose
- SAC Says Cooperation With U.S. No Longer ‘Unconditional’
- Credit Swaps in U.S. Fall as Leading Indicators, Sentiment Rise
- Puma Biotech Gains After Rival Drug Data Show No Threat
- J&J Will Stop Sales of Metal-on-Metal Hip Replacements
- Sanofi, French Government at Odds Over Fate of Research Site
- Expected Earnings Growth for Industries in Stoxx 600
- Petrobras, Merck Lead $54 Billion of Company Bond Sales in U.S.
- Merck KGaA Doesn’t Rule Out Pursuing Lung-Cancer Vaccine
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page